SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 1-A - Offering Statement [Regulation A]:
SEC Accession No. 0001213900-21-038654
Filing Date
2021-07-26
Accepted
2021-07-26 16:30:58
Documents
10

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-A  
1 primary_doc.xml 1-A 13343
2 PRELIMINARY OFFERING CIRCULAR ea144669-1a_emeraldhealth.htm PART II AND III 1016326
3 LOAN TERMINATION AGREEMENT DATED JUNE 1, 2021 BETWEEN THE COMPANY AND EMERALD HE ea144669ex3-4_emeraldhealth.htm EX1A-3 HLDRS RTS 12795
4 FORM OF SUBSCRIPTION AGREEMENT ea144669ex4-1_emeraldhealth.htm EX1A-4 SUBS AGMT 102322
5 CONSENT OF DELOITTE & TOUCHE LLP ea144669ex11-1_emeraldhealth.htm EX1A-11 CONSENT 2028
6 OPINION OF GREENBERG TRAURIG, P.A. ea144669ex12-1_emeraldhealth.htm EX1A-12 OPN CNSL 10324
7 GRAPHIC image_001.jpg GRAPHIC 7629
8 GRAPHIC image_002.jpg GRAPHIC 42764
9 GRAPHIC image_003.jpg GRAPHIC 50994
10 GRAPHIC ex12-1_001.jpg GRAPHIC 11478
  Complete submission text file 0001213900-21-038654.txt   1314244
Mailing Address 5910 PACIFIC CENTER BLVD SUITE 320, SAN DIEGO CA 92121
Business Address 5910 PACIFIC CENTER BLVD SUITE 320, SAN DIEGO CA 92121 (858) 352-0622
Emerald Health Pharmaceuticals Inc. (Filer) CIK: 0001700800 (see all company filings)

IRS No.: 820669961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 1-A | Act: 33 | File No.: 024-11591 | Film No.: 211114521
SIC: 2834 Pharmaceutical Preparations